Venous Thromboembolism – Epidemiology – Emerging Markets

  • The number of diagnosed VTE events in the countries under study will increase by 31% over the 10-year forecast period, from 1.6 million to 2.1 million.
  • Of the countries considered in this analysis, Russia has the highest diagnosed event rate of VTE: 2.95 per 1,000 per year.
  • Fifty-three percent of all diagnosed VTE events in the countries under study are considered provoked VTE, and 47% are unprovoked VTE.
  • The average age at VTE occurrence in the countries under study is 62, and 60% of the events occur in females.

Table of contents

  • Venous Thromboembolism - Epidemiology - Emerging Markets
    • Introduction
      • Key Findings
        • Key Updates
      • Diagnosed Incidence of Venous Thromboembolism Among People of All Ages in 2021 and 2031
      • Relative Sizes of Factors Contributing to the Trend in the Diagnosed Incidence of Venous Thromboembolism Over the Next 10 Years
      • Analysis of the Diagnosed Venous Thromboembolism Events by Etiology
      • Number of Additional Events of Venous Thromboembolism Incurred Over the Period 2021-2031 in the Countries Under Study Due to Trends in Economic Growth
    • Epidemiology Data
    • Methods
      • Diagnosed Events of Venous Thromboembolism
      • Venous Thromboembolism Events by Etiology
      • Venous Thromboembolism Events by Cancer Association
      • Venous Thromboembolism Events by Recurrence
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Venous Thromboembolism
        • Studies Excluded from the Analysis of Venous Thromboembolism
      • Risk/Protective Factors
        • Risk/Protective Factors for Venous Thromboembolism
      • Bibliography
      • Abbreviations
      • Glossary